ASH launches digital, open-access journal

November 29, 2016

(WASHINGTON, November 29, 2016) -- Blood has led the way in experimental and clinical hematologic research as the flagship journal of the American Society of Hematology (ASH). Launching today, the open-access online journal Blood Advances will fill a niche that complements and expands on topics covered in Blood while also transforming the conversation between authors and readers through innovative communication tools.

Taking full advantage of its digital publication model, Blood Advances will emphasize multimedia, a rapid and continuous publication format, and the ability to readily comment on manuscripts, case studies, and debates via discussion boards. The peer-reviewed journal will regularly relay findings through visual abstracts, three-dimensional images, video, and podcasts.

"Journals are critical to the way scientists communicate, and through Blood Advances we can pioneer new means of interactive, collaborative discussion," said Editor-in-Chief Robert Negrin, MD, of Stanford University. "Blood Advances stands ready to turn tradition on its head by emphasizing social interaction and visual media." ASH's new journal will allow readers to share thoughts and images directly to social media as well as to join discussions within the journal's website.

Another key feature of this new publication is there will be unrestricted access. "We have seen an explosion of progress in hematology at an unprecedented rate," noted Dr. Negrin. "We've made Blood Advances open-access in order to foster global discussion around the latest-breaking science."

Blood Advances will be a hub for hypothesis-generating papers, pilot studies, and commentary that can spark conversation. As a complement to Blood, the new journal will focus on valuable areas, including but not limited to vascular biology, immunology, gene therapy, hematologic malignancies, and epidemiology. In addition to original manuscripts, Blood Advances will publish case reports of exceptional novelty, scientific case reports called stimulus reports, point-counterpoint discussions, and educational materials for the practicing hematologist. Blood Advances will also host a series of short talks on topics of interest to hematologists and scientists.

Included in the inaugural issue -- a one-time print publication that will be distributed at the 58th ASH Annual Meeting and Exposition --are discussions on the use of platelets as immune sensing cells and new perspectives on hemostasis, as well as studies on sickle cell disease variants in sub-Saharan Africa, therapeutic solutions for multiple forms of thrombocytopenia, and a novel means of counteracting the effects of hypoxia in the tumor microenvironment.

Dr. Negrin will introduce Blood Advances to the more than 27,000 attendees expected at the ASH Annual Meeting at the beginning of the Plenary Scientific Session on Sunday, December 4, at 2:00 p.m. in Hall AB of the San Diego Convention Center.

"Blood Advances promises to be one of the greatest new tools for hematologists to advance our field," said ASH President Charles S. Abrams, MD, of the University of Pennsylvania. "It's only natural that we would use the premier hematology event to unveil it."
-end-
Read, submit, and sign up for weekly table of contents alerts at http://www.bloodadvances.org.

The American Society of Hematology (http://www.hematology.org) is the world's largest professional society concerned with the causes and treatment of blood disorders. Its mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology. ASH publishes Blood (http://www.bloodjournal.org), the most cited peer-reviewed publication in the field, which is available weekly in print and online. In 2016, ASH launched Blood Advances (http://www.bloodadvances.org), an online, peer-reviewed open-access journal.

American Society of Hematology

Related Hematology Articles from Brightsurf:

Study finds gender disparities in hematology research success
Hematologists who complete a mentored training program experience greater levels of academic success than those who do not; however, a study published today in Blood Advances suggests a slight discrepancy in success levels between male and female hematologists.

Survey suggests mentorship in medical school is vital to future of hematology
A survey of US hematology-oncology fellows suggests medical school plays an important role in shaping their interest in pursuing careers in hematology, particularly when students are exposed to hematology and oncology as part of core clerkships in internal medicine and pediatrics.

JAK inhibitors associated with aggressive lymphoma
Austrian researchers have discovered that a small number of patients taking targeted drugs known as Janus kinase (JAK) inhibitors to treat myelofibrosis may develop aggressive lymphomas.

For young adults with blood cancer, pediatric centers may improve survival
Adolescents and young adults with acute leukemia have a survival advantage if they receive treatment at a pediatric cancer center versus an adult center, according to a new study.

Global hematology diagnostics market estimated to expand at a robust CAGR over 2021
Hematology includes various IVD technologies such as blood analysis, flow cytometry, immunodiagnostics, molecular diagnostics, hemostasis, histology, and cytology.

Late-breaking hematology abstracts signal new, near-term therapeutic options for patients
In four clinical trials being presented today during the 59th American Society of Hematology (ASH) Annual Meeting and Exposition in Atlanta, researchers report promising results suggesting patients with blood disorders and several types of cancer will soon have significantly expanded options for treatment.

American Society of Hematology announces top trainee abstracts of 2016 ASH Annual Meeting
The American Society of Hematology (ASH) is pleased to recognize the following trainees with the highest-scoring abstracts in the categories of undergraduate student, medical student, graduate student, resident physician, and postdoctoral fellow at the 58th ASH Annual Meeting Dec.

ASH to expand family of blood journals with launch of new cutting-edge publication
The American Society of Hematology (ASH) will launch an open-access journal to complement Blood, its flagship publication and the most-cited journal in hematology.

Study finds common genetic variants that double risk for blood clots in African Americans
New research published online today in Blood the Journal of the American Society of Hematology, identifies common genetic variants predominantly found in African Americans that double their risk for blood clots.

Mount Sinai researchers present results at American Society of Hematology Meeting
Icahn School of Medicine at Mount Sinai researchers will present several landmark studies at the 2015 American Society of Hematology meeting Dec.

Read More: Hematology News and Hematology Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.